Sentence examples for original cardiovascular from inspiring English sources

Subtle differences among different data sources did not affect original cardiovascular risk probabilities.

ECMO is certainly among the greatest recent advances, making a surgical theater technique widely available in the critical care setting for clinical conditions far away from the original cardiovascular indications.

Simulation studies were then conducted using original (cardiovascular history excluded) and modified (cardiovascular history included) United Kingdom Prospective Diabetes Study UKPDSS) models; the predicted event rates were then compared with the observed event rates for all studies.

There may be potential measurement errors/biases and the data did not include date of any original cardiovascular disease event; The findings from this study may not be generalisable to rest of UK.

For risk assessment, the original Prospective Cardiovascular Münster (PROCAM) score was used [ 10].

The original 1992 Cardiovascular Life Expectancy model was similarly validated against the data set from the Lipid Research Clinic cohort [ 32].

The system information was categorized into six categories based on the first letter of the diagnostic code recorded; joints, skin and hooves, respiratory, skeletal, whole body, and other (including the original systems cardiovascular, digestive, reproductive, ear and eye, muscular and neurological).

CCC v2 has ten CCC categories: the original 9 (cardiovascular, respiratory, neuromuscular, renal, gastrointestinal, hematologic or immunologic, metabolic, other congenital or genetic, and malignancy) and a new category of conditions (premature and neonatal) arising in the perinatal period that are indicative of likely CCC status.

In addition, there is one original contribution concerning cardiovascular aspects of the CgA peptide catestatin (Penna et al. 2010).

Already in 2000 and 2001, the WHI Data and Safety Monitoring Board recommended that the participating women should be informed that the original hypothesis of cardiovascular protection was no longer likely, but that the trial would continue because the balance of risks and benefits remained uncertain.

We conducted a prospective cohort study of a large UK primary care population using a similar method to our original analysis for predicting cardiovascular risk (QRISK2).